Cannabigerol Gummies for Recovery After Bladder Removal Surgery for Bladder Cancer
Tests cannabigerol gummies around surgery in adults having bladder cancer removed.
Plain-language title generated from the registry record
Registry title: The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy
Key facts
- Where
- Palo Alto, United StatesSee the site
- Phase
- Early phase 1
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults in California with non-metastatic bladder cancer who are about to have radical cystectomy with urinary diversion. They will take cannabigerol gummies around the time of surgery.
- Age
- 18 years or older
- Sex
- Men and women can join
- Disease stage
- Non-metastatic bladder cancer, scheduled for radical cystectomy and urinary diversion
- Earlier treatment
- No CBD, cannabigerol or THC use in the last 30 days
Main reasons for not taking part
- History of substance abuse
- History of psychosis or schizophrenia
- CBD, cannabigerol or THC use in the last 30 days
- Pregnant or breastfeeding
- Heart attack or acute coronary syndrome in the 90 days before surgery
Read by machine on 9 November 2026.
Where in United States
- Stanford UniversityPalo Alto, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Stanford University
- Trial code
- NCT07577999
- Record updated
- 23 July 2026
- Original description
This will be an open-label, single group supportive care pilot study in which patients are given cannabinoid gummies in the perioperative setting to alleviate RC/UD symptoms and improve quality of life. The primary objective will be to evaluate the safety and tolerability of a cannabigerol supplement used perioperatively (from 14 days prior to surgery to 30 days following surgery) by patients undergoing radical cystectomy with urinary diversion (RC/UD).Read full original descriptionShow less
The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy
This will be an open-label, single group supportive care pilot study in which patients are given cannabinoid gummies in the perioperative setting to alleviate RC/UD symptoms and improve quality of life. The primary objective will be to evaluate the safety and tolerability of a cannabigerol supplement used perioperatively (from 14 days prior to surgery to 30 days following surgery) by patients undergoing radical cystectomy with urinary diversion (RC/UD).
Inclusion: 18 years of age or older; Non-metastatic bladder cancer scheduled to undergo radical cystectomy and urinary diversion; Patient is able to understand consent and is willing and able to provide written informed consent; Patient makes their own medical decisions; Lives in state of California; Patient is able and willing to refrain from using any non-study cannabis during the screening and treatment phases of the study; Females of childbearing potential to utilize an acceptable birth control method while consuming the gelatin-based chewable medication; Be able to read and understand the study questionnaires; Patient agrees to not to operate heavy machinery or engage in activities that require mental alertness while taking the gelatin-based chewable cannabigerol medication, as these substances may cause drowsiness.
Exclusion: Patients who have had heart attack or acute coronary syndrome in the 90 days prior to surgery; History of substance abuse; History of psychosis or schizophrenia; CBD or Cannabigerol usage in the last 30 days; THC usage in the last 30 days; Pregnant or breastfeeding individuals.